Green Stock News Green Stock News

XPHYTO THERAPEUTICS OTCMKTSXPHYF STOCK QUOTE

https://www.xphyto.com/

LATEST NEWS FROM XPHYTO THERAPEUTICS

October 12, 2021
XPhyto Reports Development Update for its Drug Delivery Business
October 8, 2021
Xphyto Announces Engagement of Consultants for Marketing and Promotional Activities
September 8, 2021
XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab
August 30, 2021
XPhyto Launches First Commercial Biosensor for Oral Disease
July 28, 2021
XPhyto’s Acquisition Target, 3a-Diagnostics, Reports Breakthrough Identification of COVID-19 Biosensor Candidates
July 20, 2021
XPhyto Signs Transformative Acquisition Agreement With 3a-Diagnostics, to Enter Hi-Tech Biosensor Market and Expand Its Diagnostic Product Portfolio
July 2, 2021
XPhyto Announces Advertising Agreement with Agora Internet Relations Corp.
June 30, 2021
XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test
June 17, 2021
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO of XPhyto Therapeutics Corp.
June 15, 2021
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies
June 8, 2021
XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies
May 20, 2021
XPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany
May 13, 2021
XPhyto Provides Update on Drug Formulation and Development Business
May 7, 2021
XPhyto Establishes Proof of Concept Station for Point-of-Care 25-minute COVID-19 PCR Test in Germany
May 6, 2021
InvestorBrandNetwork Announces Gamechangers LIVE Interview with XPhyto Therapeutics Corp. CEO and Director Hugh Rogers
April 28, 2021
XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test
April 21, 2021
XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test
April 20, 2021
XPhyto adds Top-Level Executive Talent to its Global Operations
March 29, 2021
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test
March 18, 2021
XPhyto announces European Approval for 25 Minute COVID-19 PCR Test
March 10, 2021
XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test
March 4, 2021
XPhyto Completes Corporate Rebranding and Launches New Website
February 26, 2021
XPhyto Provides Updated Comments on Promotional and Marketing Activity
February 24, 2021
XPhyto Places First Order for 25-Minute Covid-19 RT-PCR Tests
February 22, 2021
XPhyto Builds Commercial Team to Launch 25-Minute Covid-19 RT-PCR Test
February 19, 2021
XPhyto Reports Vektor Pharma GMBH Lawsuit
February 16, 2021
XPhyto European CE-IVD Application for 25-Minute COVID-19 RT-PCR Test
February 10, 2021
XPhyto Adds Mescaline Production to Psychedelic Medicine Programs
February 3, 2021
XPhyto Announces Psychedelic Pharmaceutical Production Agreement
January 28, 2021
XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact
January 25, 2021
XPhyto Provides Comments on Promotional and Marketing Activity